WeSearch

US Kratom Use Surges 65-Fold in 13 Years

·2 min read · 0 reactions · 0 comments · 29 views
US Kratom Use Surges 65-Fold in 13 Years
TL;DR · WeSearch summary

Kratom use in the US has surged dramatically, with reported exposures increasing from 19 in 2010 to 1242 in 2023. States that have banned kratom experienced lower rates of severe medical outcomes compared to those with fewer regulations. The findings highlight the need for more research to inform legislative decisions regarding kratom use and safety.

Key facts
About this source

Medscape files mainly under health. We currently carry 231 of its stories.

Original article
Medscape
Read full at Medscape →

Story provenance

Source · retrieval · rights · ranking — open for full record
inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisherMedscape
Canonical URLhttps://www.medscape.com/viewarticle/us-kratom-use-surges-65-fold-13-years-2026a1000fx2?src=rss
Publication timeMon, 18 May 2026 04:24:34 EDT
Retrieval time2026-05-18T08:34:56.132Z
Last seen2026-05-18T08:34:56.132Z
Headline sourcePublisher (no WeSearch rewrite)
Excerpt sourcepublisher body
Excerpt methodFirst ~120 words (~800 chars) of extracted publisher body, fair-use limited.
SummaryWeSearch · cerebras-chat (WeSearch summarizer)
Summary source textcontentText
Citation coverageSummary is a WeSearch-generated derivative; primary citation is the original publisher URL.
ClusterCEC0RJ3CC-B9
Cluster logicGrouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reasonStory pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visitYes — open original
Substitutes article?No — link-out required for full text

Rights status (four layers)

Publisher-declared
No publisher-confirmed rights record for this source yet.
Machine-readable
No source-specific machine-readable restriction detected beyond the public feed.
WeSearch interpretation
WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.
Unknown
Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing May the item be indexed (stored, ranked, made findable)? Allowed
Snippet May a short excerpt of the publisher's text be shown? Allowed
AI summary May WeSearch generate its own short summary of the article? Limited
Retrieval / RAG May the content be exposed for third-party retrieval-augmented generation? Not asserted
Model training May the content be used to train AI models? Not asserted
Commercial reuse May the content be reused commercially? Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Opening excerpt (first ~120 words) tap to expand

TOPLINE:Kratom (a plant-derived psychoactive substance) exposures reported to US poison centers increased from 19 in 2010 to 1242 in 2023, new research showed. However, states that banned kratom had significantly lower rates of exposures and severe medical outcomes compared with states with the Kratom Consumer Protection Act (KCPA) or no regulation.METHODOLOGY:A retrospective observational study included data for nearly 9000 kratom-related exposures reported between 2010 and 2023 to the National Poison Data System.Overall, 61% of the cases involved single-substance exposure; 91% occurred in adults, and 69% occurred in men.US states were classified by kratom regulatory status into four categories: unrestricted (no regulations), KCPA, local restrictions (KCPA in at least one county but no…

Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from Medscape